Nilai Total Perusahaan: allovir.com (ALVR)
The price trajectory for AlloVir, Inc. (ALVR) shown below on the GURU.Markets platform, where the Enterprise Value is , confirms the asset's status as a defensive instrument independent of global economic fluctuations. The business focuses on developing cellular antiviral therapies for transplant patients. Simultaneously, AlloVir, Inc. (ALVR) is implementing eco-friendly chemical disposal standards and energy-efficient storage for biological samples.
AlloVir (ALVR) - rincian metrik lan laporan keuangan
Enterprise Value (EV) represents the total buyout price of a business, combining market capitalization with net debt to determine the objective value of assets. The price action of the actual business buyout reflects the impact of cash reserves amid the freeze of clinical trials at AlloVir, Inc. (ALVR), allowing for an assessment of the company's financial stability during a deep revision of its R&D pipeline.